Navigation Links
BioMarin Announces Roll-Out of National PKU Registry
Date:8/21/2008

Conference Call and Webcast to Be Held Today at 4:30 p.m. ET (21:30 CET)

NOVATO, Calif., Aug. 21 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today the roll-out of the national PKU Demographics, Outcomes and Safety Registry (PKUDOS). The registry is open to all PKU clinics within the United States, and all patients screened for Kuvan responsiveness are eligible for enrollment in the registry. Also, from September 1, 2008 until December 31, 2008, to facilitate enrollment in the registry, new patients at clinics participating in the registry will be able to receive 45 days of free drug while individual insurance coverage is secured.

"We are excited to initiate the first PKU patient registry and believe that it will substantially strengthen the available data on a variety of PKU patient populations, including some less studied, such as children under four years of age and maternal PKU patients," said Jean-Jacques Bienaime, Chief Executive Officer of BioMarin. "Approximately half of the PKU clinics have already expressed interest in participating in the registry program.

"Moreover, at a very minimal cost to BioMarin, we will be able to bypass the current two- to eight-week processing time between BPPS referral and initiation of commercial therapy, by providing an initial supply of Kuvan at no cost to patients. This will allow physicians to test for responsiveness to Kuvan without the need to first secure insurance coverage. We have also received numerous requests to support PKU clinics planning patient information days to further stimulate interest in Kuvan screening, and we are pleased to help advance education in the PKU community," added Mr. Bienaime.

BioMarin will host a confere
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. BioMarin to Host Second Quarter 2008 Financial Results Conference Call and Webcast on Tuesday, August 5 at 5:00 p.m. ET (23:00 CET)
2. BioMarin to Present at the Collins Stewart Growth Conference
3. SciQuest Announces Newest Life Sciences Customer; BioMarin Pharmaceutical Drives Spending Effectiveness with Automated, Intuitive Procurement
4. BioMarin Announces Program for ERT for Treatment of MPS IVA - Morquio A Syndrome
5. BioMarin to Host Research and Development Day June 5th
6. BioMarin to Present at the Bank of America Healthcare Conference
7. BioMarin Announces First Quarter 2008 Financial Results
8. BioMarin to Present at the Morgan Stanley Healthcare Conference
9. BioMarin to Host First Quarter 2008 Financial Results Conference Call and Webcast on Tuesday, April 29 at 5:00 p.m. ET (23:00 CET)
10. BioMarin Announces Fourth Quarter and Full Year 2007 Financial Results
11. BioMarin to Present at the Merrill Lynch 2008 Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... 21, 2013 PathoGenetix, Inc., a commercial-stage ... typing, announced today that it has successfully identified and ... strains obtained from the Centers for Disease Control and ... technology. The findings are detailed in a poster ... Society for Microbiology in Denver on Monday. , The ...
(Date:5/21/2013)... May 21, 2013 Clinovo's new ... 8-week training program starting on June 11th, 2013. The ... trial professionals reach the next step in their professional ... in Palo Alto, and streamed online. , Taught by ... papers, Clinovo's new “CDISC Standards: Theory and Application” class ...
(Date:5/20/2013)... Grace Century , an international ... science and health related private equity projects, has announced ... Project Team. Dergham's expertise in finance and international law ... Grace Century as it continues to look at more ... holds both an under graduate degree from the University ...
(Date:5/20/2013)... May 20, 2013  MiMedx Group, Inc. (NASDAQ: ... of patent protected regenerative biomaterials and bioimplants processed from ... a revolving line of credit with Bank of America.  ... by the Company,s accounts receivable and inventory, allows MiMedx ... 2014.  The facility will be used for general corporate ...
Breaking Biology Technology:New Genotyping System Identifies Pathogenic E. coli Outbreak Strains 2New Genotyping System Identifies Pathogenic E. coli Outbreak Strains 3Clinovo Launches TechTrainings on CDISC Standards 2Dalia Dergham Joins Grace Century FZ LLC International Project Team 2
... , , , PRINCETON, ... Company) (OTC Bulletin Board: DORB), a late-stage biopharmaceutical company, announced ... Officer, will present at the Rodman & Renshaw 11th Annual ... at 4:55 PM on Thursday, September 10, 2009 in the ...
... - OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI ) announced today that ... , , - Rodman & Renshaw 11th ... September 10, 2009 at 12:30 p.m. Eastern Time in the Fahnestock Salon, ... Hotel in New York City., - Thomas ...
... 2 Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced that ... Robert W. Baird & Co. 2009 Health Care Conference ... 2009 Health Care Conference in New York, New York, on September 9, 2009 ... Thomas Weisel Partners Healthcare Conference , Subsequently, Onyx will ...
Cached Biology Technology:DOR BioPharma to Present at the Rodman & Renshaw Annual Global Investor Healthcare Conference 2DOR BioPharma to Present at the Rodman & Renshaw Annual Global Investor Healthcare Conference 3DOR BioPharma to Present at the Rodman & Renshaw Annual Global Investor Healthcare Conference 4OncoGenex Pharmaceuticals to Webcast Presentations at September Investor Conferences 2Onyx Pharmaceuticals to Present at Two Upcoming Healthcare Conferences 2
(Date:5/21/2013)... infections occur in the body, stem cells in ... and differentiating into mature immune cells that can ... can deplete these cell populations, potentially leading to ... cancer. Now, a team of researchers led by ... has found that, in mouse models, the molecule ...
(Date:5/21/2013)... and health stores, phosphatidylserine is a natural food ... to improve cognition and slow memory loss, it,s ... impairment. Now a team headed by Prof. Gil ... University,s Department of Human Molecular Genetics ... functioning of genes involved in degenerative brain disorders, ...
(Date:5/21/2013)... of biomass experts , Where? Copenhagen, ... 03-07 June 2013 , Why? ... assessment, market and policy developments, manufacturing and installation, drawing ... benefiting from its 2013 edition from a record of ... countries, more than 240 plenary and oral presentations, more ...
Breaking Biology News(10 mins):Keeping stem cells strong 2Common food supplement fights degenerative brain disorders 221st European Biomass Conference and Exhibition 221st European Biomass Conference and Exhibition 321st European Biomass Conference and Exhibition 4
... the International Osteoporosis Foundation (IOF) in its 2009 publication, ... more than 50% of all osteoporotic fractures will occur ... there is a growing need for advanced clinical training ... epidemiology and specificities of osteoporosis and related bone disorders ...
... research could eventually lead to new approaches for controlling ... which are caused by trypanosomes carried by the bloodsucking ... reproduction evolved very early and is now ubiquitous in ... living organisms except bacteria). However, real evidence is ...
... of mucus associated with chronic bronchitis, according to a ... indicates cigarette smoke suppresses a protein that causes the ... bronchitis patients. The findings were published online ahead ... American Journal of Respiratory and Critical Care Medicine ...
Cached Biology News:Shining a light on trypanosome reproduction 2Cigarette smoking increases production of mucus in patients with bronchitis 2Cigarette smoking increases production of mucus in patients with bronchitis 3
... We deliversoluble protein or No Charge ... the best soluble protein results , 24 ... submitted , Powerful results on your most ... Optimization Service (SOS) uses proprietary tools and ...
... for proteomic scale kinase profiling, quantitative ... drug discovery research built on the ... synthesis platform. These microarrays are available ... Kinase Substrate - Peptide Microarray Service. ...
... immunological studies, vaccine development, and biosensor ... powerful Paraflo microfluidic on-chip synthesis platform. ... of our comprehensive Epitope Peptide Microarray ... Probe content is completely customer ...
... Introducing our Regulatory Edition of Molecular ... imaging systems for life science research and ... supports compliance with U.S. Food and Drug ... Part 11 Electronic Records; Electronic Signatures [21 ...
Biology Products: